Impact of Iron Stores on Wound Healing in Plastic Surgery (IRONPLAST)

August 17, 2020 updated by: Assistance Publique - Hôpitaux de Paris
In breast reduction surgery, delayed wound healing may increase surgical site infections, cutaneous necrosis and may be related to psychological harm.Some risk factors have been identified : smoking, diabetes, overweight. A normal healing involve cellular and biochemical reactions in which iron plays an important role such as cellular respiration, redox reactions and regulation of genes involved in the cell cycle. This trial will study the relationship between iron stores and postoperative wound healing after bilateral breast reduction surgery in patients without preoperative anaemia.The primary outcome of this trial is the comparison of wound healing at post operative day 15, between patients with and without iron deficiency.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Paris, France
        • Saint Louis Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Sampling Method

Non-Probability Sample

Study Population

Cohort of woman who had a scheduled bilateral breast reduction surgery without anemia

Description

Inclusion Criteria:

  • age >18 years
  • female
  • scheduled bilateral breast reduction surgery
  • biological exams with ferritin and transferrin saturation coefficient taken the day before surgery
  • No anemia : haemoglobin >=12g/dL (preoperative biological assessment )
  • if genetic disease of haemoglobin, haemoglobin between 10 and 12g/dL and no Anaemia by iron deficiency
  • absence of clinical inflammatory syndrome (no clinical signs of infection or no fever)
  • non-opposition of the patient to participate

Exclusion Criteria:

  • Anaemia by iron deficiency

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of good breast tissue healing on each breast
Time Frame: 15 days after surgery
Good healing is defined as a score of 0, 1 or 2 on a 16 points-specifc scale. The scale evaluate proportion of disunity for periareolar vertical and horizontal incisions
15 days after surgery

Secondary Outcome Measures

Outcome Measure
Time Frame
Evaluation of healing on the 16 points specific scale
Time Frame: 15 days after surgery
15 days after surgery
Proportion of early complications
Time Frame: up to 15 days after surgery
up to 15 days after surgery
Proportion of closed drainage orifices
Time Frame: 15 days after surgery
15 days after surgery
Correlation between serum ferritin levels before surgery and score on the healing scale
Time Frame: 15 days after surgery
15 days after surgery
Intra-class correlation coefficient for the healing scale
Time Frame: 15 days after surgery
15 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2020

Primary Completion (Anticipated)

December 15, 2020

Study Completion (Anticipated)

December 15, 2020

Study Registration Dates

First Submitted

February 17, 2020

First Submitted That Met QC Criteria

February 17, 2020

First Posted (Actual)

February 19, 2020

Study Record Updates

Last Update Posted (Actual)

August 19, 2020

Last Update Submitted That Met QC Criteria

August 17, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • APHP190575

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Iron-deficiency

3
Subscribe